245 related articles for article (PubMed ID: 27977466)
1. Extremely Small Pseudoparamagnetic Iron Oxide Nanoparticle as a Novel Blood Pool T1 Magnetic Resonance Contrast Agent for 3 T Whole-Heart Coronary Angiography in Canines: Comparison With Gadoterate Meglumine.
Park EA; Lee W; So YH; Lee YS; Jeon BS; Choi KS; Kim EG; Myeong WJ
Invest Radiol; 2017 Feb; 52(2):128-133. PubMed ID: 27977466
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced magnetic resonance angiography: evaluation of the high relaxivity low diffusible gadolinium-based contrast agent P846 in comparison with gadoterate meglumine in rabbits at 1.5 Tesla and 3.0 Tesla.
Peldschus K; Hamdorf M; Robert P; Port M; Graessner J; Adam G; Herborn CU
Invest Radiol; 2008 Dec; 43(12):837-42. PubMed ID: 19002055
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced magnetic resonance angiography in rabbits: evaluation of the gadolinium-based agent p846 and the iron-based blood pool agent p904 in comparison with gadoterate meglumine.
Kinner S; Maderwald S; Parohl N; Albert J; Corot C; Robert P; Barkhausen J; Vogt FM
Invest Radiol; 2011 Aug; 46(8):524-9. PubMed ID: 21577130
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced whole-heart coronary magnetic resonance angiography at 3.0 T: comparison with steady-state free precession technique at 1.5 T.
Liu X; Bi X; Huang J; Jerecic R; Carr J; Li D
Invest Radiol; 2008 Sep; 43(9):663-8. PubMed ID: 18708861
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced whole-heart MR coronary angiography at 3.0 T using the intravascular contrast agent gadofosveset.
Prompona M; Cyran C; Nikolaou K; Bauner K; Reiser M; Huber A
Invest Radiol; 2009 Jul; 44(7):369-74. PubMed ID: 19554666
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced magnetic resonance angiography: P792 blood pool agent versus Gd-DOTA in rabbits at 3.0 T versus 1.5 T.
Herborn CU; Watkins DM; Baumann S; Robert P; Corot C; Runge VM
Invest Radiol; 2007 Sep; 42(9):622-8. PubMed ID: 17700277
[TBL] [Abstract][Full Text] [Related]
7. Equilibrium phase MR angiography of the aortic arch and abdominal vasculature with the blood pool contrast agent CMD-A2-Gd-DOTA in pigs.
Kroft LJ; Doornbos J; Benderbous S; de Roos A
J Magn Reson Imaging; 1999 Jun; 9(6):777-85. PubMed ID: 10373025
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
Nassenstein K; Breuckmann F; Hunold P; Barkhausen J; Schlosser T
Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
[TBL] [Abstract][Full Text] [Related]
9. 3D whole-heart coronary MR angiography at 1.5T in healthy volunteers: comparison between unenhanced SSFP and Gd-enhanced FLASH sequences.
Gweon HM; Kim SJ; Lee SM; Hong YJ; Kim TH
Korean J Radiol; 2011; 12(6):679-85. PubMed ID: 22043149
[TBL] [Abstract][Full Text] [Related]
10. Use of 2D sensitivity encoding for slow-infusion contrast-enhanced isotropic 3-T whole-heart coronary MR angiography.
Yu J; Paetsch I; Schnackenburg B; Fleck E; Weiss RG; Stuber M; Jahnke C
AJR Am J Roentgenol; 2011 Aug; 197(2):374-82. PubMed ID: 21785083
[TBL] [Abstract][Full Text] [Related]
11. High spatial resolution and high contrast visualization of brain arteries and veins: impact of blood pool contrast agent and water-selective excitation imaging at 3T.
Spuentrup E; Jacobs JE; Kleimann JF; Wiethoff AJ; Poggenborg J; Brinker G; Loehr M; Möller-Hartmann W; Botnar RM; Ernestus RI; Lackner KJ
Rofo; 2010 Dec; 182(12):1097-104. PubMed ID: 20803412
[TBL] [Abstract][Full Text] [Related]
12. 3.0-T whole-heart coronary magnetic resonance angiography: comparison of gadobenate dimeglumine and gadofosveset trisodium.
Raman FS; Nacif MS; Cater G; Gai N; Jones J; Li D; Sibley CT; Liu S; Bluemke DA
Int J Cardiovasc Imaging; 2013 Jun; 29(5):1085-94. PubMed ID: 23515949
[TBL] [Abstract][Full Text] [Related]
13. Improved coronary magnetic resonance angiography using gadobenate dimeglumine in pediatric congenital heart disease.
Silva Vieira M; Henningsson M; Dedieu N; Vassiliou VS; Bell A; Mathur S; Pushparajah K; Figueroa CA; Hussain T; Botnar R; Greil GF
Magn Reson Imaging; 2018 Jun; 49():47-54. PubMed ID: 29339139
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.
Attenberger UI; Runge VM; Jackson CB; Baumann S; Birkemeier K; Michaely HJ; Schoenberg SO; Reiser MF; Wintersperger BJ
Invest Radiol; 2009 May; 44(5):251-6. PubMed ID: 19550376
[TBL] [Abstract][Full Text] [Related]
15. Coronary magnetic resonance angiography: experimental evaluation of the new rapid clearance blood pool contrast medium P792.
Taupitz M; Schnorr J; Wagner S; Kivelitz D; Rogalla P; Claassen G; Dewey M; Robert P; Corot C; Hamm B
Magn Reson Med; 2001 Nov; 46(5):932-8. PubMed ID: 11675645
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced whole-heart coronary MRA using Gadofosveset 3.0 T versus 1.5 T.
Prompona M; Cyran C; Nikolaou K; Bauner K; Reiser M; Huber A
Acad Radiol; 2010 Jul; 17(7):862-70. PubMed ID: 20399687
[TBL] [Abstract][Full Text] [Related]
17. Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR-angiography at 3.0 tesla: Effects of contrast bolus length and flip angle.
Schubert T; Motosugi U; Kinner S; Colgan TJ; Sharma SD; Hetzel S; Wells S; Campo CA; Reeder SB
J Magn Reson Imaging; 2017 Jun; 45(6):1617-1626. PubMed ID: 27862577
[TBL] [Abstract][Full Text] [Related]
18. MR Angiography at 3 T of Peripheral Arterial Disease: A Randomized Prospective Comparison of Gadoterate Meglumine and Gadobutrol.
Loewe C; Arnaiz J; Krause D; Marti-Bonmati L; Haneder S; Kramer U;
AJR Am J Roentgenol; 2015 Jun; 204(6):1311-21. PubMed ID: 26001243
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of meglumine gadoterate-enhanced MR angiography (MRA) compared with time-of-flight MRA in the diagnosis of clinically significant non-coronary arterial disease: a pooled analysis of data from two clinical trials.
Shah DJ; Lim TH
Br J Radiol; 2012 May; 85(1013):596-605. PubMed ID: 22167518
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Gadopiclenol and P846, 2 High-Relaxivity Macrocyclic Magnetic Resonance Contrast Agents Without Protein Binding, in a Rodent Model of Hepatic Metastases: Potential Solutions for Improved Enhancement at Ultrahigh Field Strength.
Fries P; Massmann A; Robert P; Corot C; Laschke MW; Schneider G; Buecker A; Müller A
Invest Radiol; 2019 Sep; 54(9):549-558. PubMed ID: 31033675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
